Aviragen Therapeutics clinical trials
Acquired by Vaxart, Feb 13, 2018 · source ↗
The registry lists 1 studies whose lead sponsor is Aviragen Therapeutics. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 26, 2018.
Before and after it joined Vaxart
- First submitted before Aviragen Therapeutics became part of Vaxart
- 1
- First submitted after Aviragen Therapeutics became part of Vaxart
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Aviragen Therapeutics1 study
Something wrong with this grouping? Tell us on the Vaxart page.
Studies
Recruiting first, then most recently updated. Showing 1 of 1. All Vaxart studies →
- A Study to Compare the Oral Bioavailability of Single Doses of Three Vapendavir Drug Formulations in Healthy VolunteersCompletedNCT02877264Phase 1
Sponsor listed in the registry: Aviragen Therapeutics · First submitted before Aviragen Therapeutics became part of Vaxart